233 related articles for article (PubMed ID: 23834620)
21. Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies.
Marković V; Debeljak N; Stanojković T; Kolundžija B; Sladić D; Vujčić M; Janović B; Tanić N; Perović M; Tešić V; Antić J; Joksović MD
Eur J Med Chem; 2015 Jan; 89():401-10. PubMed ID: 25462255
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
23. The products of the reaction between 6-amine-1,3-dimethyl uracil and bis-chalcones induce cytotoxicity with massive vacuolation in HeLa cervical cancer cell line.
Solano JD; González-Sánchez I; Cerbón MA; Guzmán Á; Martínez-Urbina MA; Vilchis-Reyes MA; Martínez-Zuñiga EC; Alvarado C; Quintero A; Díaz E
Eur J Med Chem; 2013 Feb; 60():350-9. PubMed ID: 23314048
[TBL] [Abstract][Full Text] [Related]
24. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
25. Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.
Konieczny MT; Konieczny W; Sabisz M; Skladanowski A; Wakieć R; Augustynowicz-Kopeć E; Zwolska Z
Eur J Med Chem; 2007 May; 42(5):729-33. PubMed ID: 17300856
[TBL] [Abstract][Full Text] [Related]
26. Novel 3',5'-diprenylated chalcones inhibited the proliferation of cancer cells in vitro by inducing cell apoptosis and arresting cell cycle phase.
Wen Z; Zhang Y; Wang X; Zeng X; Hu Z; Liu Y; Xie Y; Liang G; Zhu J; Luo H; Xu B
Eur J Med Chem; 2017 Jun; 133():227-239. PubMed ID: 28390228
[TBL] [Abstract][Full Text] [Related]
27. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
28. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
29. Chromenylchalcones showing cytotoxicity on human colon cancer cell lines and in silico docking with aurora kinases.
Shin SY; Yoon H; Ahn S; Kim DW; Kim SH; Koh D; Lee YH; Lim Y
Bioorg Med Chem; 2013 Jul; 21(14):4250-8. PubMed ID: 23719279
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect.
Vogel S; Barbic M; Jürgenliemk G; Heilmann J
Eur J Med Chem; 2010 Jun; 45(6):2206-13. PubMed ID: 20153559
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic activity of substituted chalcones in terms of molecular electronic properties.
Kupcewicz B; Jarzęcki AA; Małecka M; Krajewska U; Rozalski M
Bioorg Med Chem Lett; 2014 Sep; 24(17):4260-5. PubMed ID: 25091929
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of synthesized 2'-oxygenated chalcone derivatives: modulation of human cell cycle phase distribution.
Rao YK; Fang SH; Tzeng YM
Bioorg Med Chem; 2004 May; 12(10):2679-86. PubMed ID: 15110849
[TBL] [Abstract][Full Text] [Related]
33. Halogenated naphthochalcones and structurally related naphthopyrazolines with antitumor activity.
Schmitt F; Draut H; Biersack B; Schobert R
Bioorg Med Chem Lett; 2016 Nov; 26(21):5168-5171. PubMed ID: 27727127
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNFα-induced nuclear factor-κB activation inhibition.
Zuo Y; Yu Y; Wang S; Shao W; Zhou B; Lin L; Luo Z; Huang R; Du J; Bu X
Eur J Med Chem; 2012 Apr; 50():393-404. PubMed ID: 22386368
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anti breast cancer activity of biphenyl based chalcones.
Sharma A; Chakravarti B; Gupt MP; Siddiqui JA; Konwar R; Tripathi RP
Bioorg Med Chem; 2010 Jul; 18(13):4711-20. PubMed ID: 20605470
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
38. Computational screening of chalcones acting against topoisomerase IIα and their cytotoxicity towards cancer cell lines.
Sangpheak K; Mueller M; Darai N; Wolschann P; Suwattanasophon C; Ruga R; Chavasiri W; Seetaha S; Choowongkomon K; Kungwan N; Rungnim C; Rungrotmongkol T
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):134-143. PubMed ID: 30394113
[TBL] [Abstract][Full Text] [Related]
39. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of novel quinoline-2-one based chalcones of potential anti-tumor activity.
Abonia R; Insuasty D; Castillo J; Insuasty B; Quiroga J; Nogueras M; Cobo J
Eur J Med Chem; 2012 Nov; 57():29-40. PubMed ID: 23043766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]